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Abstract
Neurogenin 3 (NGN3) commits pancreatic progenitors
to an islet cell fate. We have induced NGN3 expression
and identiﬁed upregulation of the gene encoding the
Ras-associated small molecular mass GTP-binding protein,
RAB3B. RAB3B localised to the cytoplasm of human
b-cells, both during the foetal period and post natally.
Genes encoding alternative RAB3 proteins and RAB27A
wereunaltered by NGN3 expression and in human adult islets
their transcripts were many fold less prevalent than those
of RAB3B. The regulation of insulin exocytosis in rodent
b-cells and responsiveness to incretins are reliant on Rab
family members, notably Rab3a and Rab27a, but not Rab3b.
Our results support an important inter-species difference in
regulating insulin exocytosis where RAB3B is the most
expressed isoform in human islets.
Journal of Endocrinology (2010) 207, 151–161
Introduction
Understanding normal b-cell development and function
underpins various efforts aimed to restore b-cells in patients
with type 1 and type 2 diabetes. During the foetal
development, the pancreas contains epithelial progenitor
cells, which give rise to the adult cell lineages, including
b-cells (Murtaugh 2007). Experiments manipulating genes in
mice have discovered a multitude of transcription factors that
regulate this transition (Wilson et al. 2003). Within a subset of
progenitors, positive for the transcription factors Sry box 9
(Sox9) and pancreas-duodenal homeobox 1 (Pdx1), the basic
helix-loop-helix (bHLH) transcription factor Neurogenin-3
(Ngn3, also known as Neurog3) becomes transiently
expressed to commit cells to an endocrine fate (Schwitzgebel
et al. 2000, Lynn et al. 2007, Seymour et al. 2007). Without
Ngn3, islet differentiation fails (Gradwohl et al. 2000).
The transcription factor has also been shown necessary
for b-cell regeneration from adult precursors (Xu et al.
2008). Strategies, such as expression microarray following
retroviral ectopic Ngn3 expression, have identiﬁed direct
genetic targets of Ngn3 encodingtranscription factors,such as
NeuroD1, paired homeobox factor 4 (Pax4), Nirenberg and
Kim (NK) homeobox family member Nkx2.2 and insuli-
noma-associated 1, all of which when inactivated in mice
impair b-cell differentiation (Sosa-Pineda et al. 1997, Sussel
et al. 1998, Huang et al. 2000, Heremans et al. 2002, Gasa et al.
2004, Smith et al. 2004, Mellitzer et al. 2006). Pdx1 is also
increased following Ngn3 expression (Gasa et al. 2004).
Several of these transcription factors downstream of Ngn3 are
then required for mature b-cell function. For instance, Pdx1
regulates GLUT2, glucokinase and insulin amyloid polypeptide
(IAPP) expression (McKinnon & Docherty 2001) and, in
association with NeuroD1, it transactivates the insulin gene
(Babu et al. 2008).
Many aspects of the b-cell phenotype are conserved across
species. Nevertheless, there are subtle differences in mature
b-cell function between mice and humans: the relative roles
of glucose transport and phosphorylation as a part of glucose
sensing (Schuit 1997); responsiveness to glucokinase activa-
tors (Johnson et al. 2007); glucose-induced desensitisation
(Zawalich et al. 1998); responses to galanin (McDonald et al.
1994) and melatonin (Ramracheya et al. 2008); the roles of
Pax4 (Brun et al. 2008) and p57Kip2 (Potikha et al. 2005)i n
b-cell proliferation; and, central to b-cell function, regulation
of the insulin promoter (Hay & Docherty 2006). This makes
direct study of human pancreas development and b-cells
worthwhile. Studying foetuses from ﬁrst trimester termin-
ation of pregnancy has provided a framework for under-
standing early human pancreas development with b-cells
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cell clusters and then within islets, where they express other
markers of maturity such as prohormone convertase 1/3,
IAPP, chromogranin A and some components of the glucose-
sensing apparatus (Piper et al. 2004, Richardson et al. 2007).
Similar studies ﬁrst identiﬁed SOX9 as important for
pancreatic development and b-cell differentiation; the
pancreata of patients with campomelic dysplasia being
hypoplastic and composed of poorly formed islets (Piper
et al. 2002). Human pancreatic progenitor cells expressing
PDX1 (Piper et al. 2004) and NGN3 transcripts have been
identiﬁed at 8 wpc (Castaing et al. 2005).
To further address the potential inter-species differences
downstream of endocrine commitment, we induced human
NGN3 expression in a cell line with similarities to human
foetal pancreatic progenitors, leading to increased expression
of the Ras-associated small molecular mass GTP-binding
protein, RAB3B. RAB3 proteins regulate intracellular
trafﬁcking and exocytosis in a range of cell types (Gonzalez
& Scheller 1999) with RAB3B recently implicated in
protecting and enhancing the function of dopaminergic
nerve terminals (Chung et al. 2009). Inactivation of either
Rab3a or Rab27, but not Rab3b, in mice causes glucose
intolerance (Yaekura et al. 2003, Aizawa & Komatsu 2005,
Kasai et al. 2005). In this study, we have identiﬁed RAB3B,
rather than RAB27A or other RAB3 isoforms, as the
predominant isoform in human islets implying an inter-
species difference and providing a new candidate for mutation
or abnormal function as a cause of diabetes and as a potential
therapeutic target for enhancing insulin secretion in humans.
Materials and Methods
Human tissue collection
The collection of human foetal material under guidelines
issued by the Polkinghorne committee has been described
previously (Piper et al. 2004, Ostrer et al. 2006). Ethical
approval was granted by the Southampton and South West
Hampshire Local Regional Ethics committee. In these
experiments, material from at least two foetuses per stage
was examined. Human islets were obtained with appropriate
ethical approval from the King’s College Hospital Islet
Transplantation Unit (King’s College Hospital, London,
UK). Pancreata were removed from non-diabetic cadaver
organ donors and islets were isolated under aseptic conditions
as described previously (Huang et al. 2004).
Immunohistochemistry and immunoblotting
Tissue preparation, immunoblotting, immunohistochemistry
and immunoﬂuorescence were performed as described
previously (Piper et al. 2004, Piper Hanley et al. 2008).
Antibodies are listed in Supplementary Table 1, see section
on supplementary data given at the end of this article with
dilutions, catalogue numbers and sources. Exceptions
to dilutions for immunoblotting were 1:1000 for NGN3
and RAB3B. For biotinylated secondary antibodies,
streptavidin (SA)–HRP (1:200, Vector Laboratories
Ltd, Peterborough, UK), SA–FITC (1:150, Sigma–Aldrich
Ltd), or SA–Texas Red (1:200; Vector Laboratories Ltd)
conjugates were used according to the manufacturers’
instructions. For bright-ﬁeld immunohistochemistry, the
colour reaction was developed following SA–HRP with
diaminobenzidine (Merck) containing 0.1% hydrogen per-
oxidase (Sigma–Aldrich Ltd). Negative controls were
omission of primary or secondary antibody.
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Figure 1 PANC-1 cells express CK19 and SOX9. (A) Consecutive
5 mm sections of the human foetal pancreas at 8 wpc stained for
CK19 and SOX9. (B) Consecutive 5 mm sections of the human adult
pancreas stained for CK19 and SOX9. (C) Dual immunoﬂuores-
cence of PANC-1 cells for SOX9 (red) and CK19 (green) counter-
stained with DAPI (blue) of the same image is shown to the right.
Size bars represent 250 mm (A and B) and 50 mm (C).
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expression
The human PANC-1 cell line (cat. no. 87092802) was
purchased from the European Cell and Animal Culture
Collection (ECACC, Salisbury, UK) and cultured in DMEM
containing 10% foetal bovine serum (FBS) and prokaryotic
antibiotics. All vectors were from Clontech Laboratories Inc.
The human NGN3 coding sequence was ampliﬁed by PCR
using primers containing HindIII and XbaI restriction sites
(forward, 50-CCCAAGCTTGACTCAAACTTACCCTT-
CCCTCTG-30; reverse, 50-GCTCTAGAGCTCCGGCC-
GGGTAGTGCT-30) and cloned using these restriction sites
into the pTRE2 vector to create pTRE2–NGN3. PANC-1
cells were transfected sequentially with pTet-On and
pTRE2–NGN3 plus pTK-Hyg using Transfast (Promega
Ltd). Stable PANC-1 clones demonstrating inducible NGN3
expression (PANC-1iNGN3)w e r ei s o l a t e di nD M E M
containing tetracycline-free FBS by selection with G418
and hygromycin according to the manufacturer’s instructions
(Clontech Laboratories). To assess the expression offunctional
NGN3 protein, the proximal 1613 bp of 50 ﬂanking region
from the mouse NeuroD1 gene was ampliﬁed to create a
luciferase construct, p-1613NeuroD1-Luc. This construct
contains two E-box motifs regulated by Ngn3 (Huang et al.
2000). Luciferase assays (Promega Corp.), as described
previously (Hanley et al. 2001), were conducted 48 h after
the addition of doxycycline (Dox) to screen PANC-1iNGN3
clones for induction of functional NGN3.
Isolation of RNA, northern blotting, reverse transcription and
real-time PCR
Total RNA was isolated from PANC-1iNGN3 cells, human
foetal pancreas and adult islets using Tri reagent (Sigma–
Aldrich Ltd) for subsequent gel electrophoresis and reverse
transcription (RT) using Superscript III (Invitrogen Ltd).
RNA gel electrophoresis was carried out under denaturing
conditions using 5 mg of total RNA per lane followed by
washing and transfer overnight to Hybond NC membrane
(Amersham Pharmacia Biotech Ltd). The membrane was
Gene Fold  induction S.E.M.
NGN3 2·98 ±0·28
RAB3B 2·50 ±0·08
B 
PANC-1iNGN3 clone Fold induction S·E·M.
Clone 9 2·24 ±0·48
Clone 15 1·71 ±0·39
Clone 40 1·45 ±0·48
Clone 51 1·97 ±0·27
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Figure 2 Inducible NGN3 expression in PANC-1 cells. (A) Northern blot analysis for NGN3 expression
following the addition of doxycycline for 48 h to a clone of PANC-1iNGN3 cells. (B) Schematic of the mouse
NeuroD1 promoter with two E-box motifs at K348/K343 and K241/K236 bp in its 50 ﬂanking region that are
regulated by Ngn3-E47 dimers (Huang et al. 2000). (C) Fold induction GS.E.M. of luciferase activity from
transient transfection of p-1613NeuroD1-Luc measured 48 h after the addition of 2 mg/ml doxycycline in
four PANC-1iNGN3 clones. (D) Fold increase GS.E.M.o fNGN3 and RAB3B expression from microarray
analysis of PANC-1iNGN3 clone 51 by adding 2 mg/ml doxycycline for 48 h. (E and F) Western blot analysis
of clone 51 PANC-1iNGN3 cells showing NGN3 (E) and RAB3B (F) protein expression following addition of
increasing concentrations of doxycycline for 48 h.
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68 8C overnight with radiolabelled DNA probes to the
NGN3 coding sequence. Following post-hybridisation
washes, the membrane was exposed to autoradiography ﬁlm
at K80 8C and developed.
Real-time PCR in the foetal tissue and the PANC-1 cells
used pre-designed Taqman Gene Expression assays for each
gene (Applied Biosystems, Warrington, UK) and an ABI
PRISM 7900HT system with standard cycling conditions.
TBP and HPRT1 were used as endogenous controls. Results
were analysed with SDS v2.1 software (Applied Biosystems)
using the relative quantiﬁcation method. mRNAwas isolated
from human pancreatic islets using the RNeasy Mini kit
(Qiagen Ltd) according to the manufacturer’s instructions and
was quantiﬁed using a Nanodrop spectrometer (NanoDrop,
Rockland, ME, USA). cDNA was synthesised and quan-
titative RT-PCR standards ranging from 10 to 10
9 copies
DNA were prepared as described previously (Persaud et al.
2002). Real-time PCR ampliﬁcation was performed using a
LightCycler rapid thermal cycler system. Reactions were
performed in 10 ml comprising nucleotides, Taq DNA
polymerase and buffer (all included in the LightCycler
FastStart Reaction Mix SYBR Green I); template cDNA;
3 mM MgCl2; and 0.5 mM primers. All PCR protocols
included an initial 10 min denaturation step and each cycle
subsequently included a ramp at 95 8C for denaturation,
annealing for 10 s at the temperatures listed in Supplementary
Table 2, see section on supplementary data given at the end of
this article and a 72 8C extension phase for 14 s (b-ACTIN)o r
18 s (all other genes). The ampliﬁcation products of both the
primer pairs were subjected to melting point analyses and
subsequent gel electrophoresis to ensure speciﬁcity of
ampliﬁcation.
Statistical analysis
Data were expressed as meansGS.E.M. Statistical analysis
used paired t-test or one-way ANOVA followed by Dunnett’s
post hoc test, as indicated. Values with P!0.05 were
considered signiﬁcant.
Results
Inducible NGN3 expression by PANC-1iNGN3 cells
In the human pancreas, cytoplasmic CK19 and nuclear SOX9
were restricted to the foetal epithelial progenitor cells and
adult ductal cells (Fig. 1A and B; Piper et al. 2004). A similar
proﬁle was identiﬁed uniformly in the human pancreatic
ductal carcinoma cell line, PANC-1 (Fig. 1C), which was
negative for amylase (data not shown), conﬁrming this cell
line as a suitable source in which to engineer inducible
NGN3 expression. Sequential stable transfection of vectors
for dox-inducible NGN3 expression resulted in the isolation
of more than 60 human PANC-1iNGN3 clones for further
analysis. These starting clones retained SOX9 and CK19
0
0·5
1
1·5
2
2·5
3
3·5
RAB3A RAB3B RAB3C RAB3D RAB27A
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n –Dox
∗
+Dox
A
B
Gene Fold induction across all
PANC-1iNGN3 clones
S.E.M.
RAB3A 1·05
RAB3B 1·85
RAB3C 1·00
RAB3D 1·15
RAB27A 1·12
0·03
0·24*
0·12
0·02
0·03
Figure 3 Expression of RAB3 family members and RAB27A
following induction of NGN3 expression in PANC-1iNGN3 cells.
(A) Expression of RAB3 isoforms and RAB27A in PANC-1iNGN3
clone 51 after 2 mg/ml doxycycline for 48 h. Bars show mean
GS.E.M. from at least two experiments. (B) Mean fold induction
GS.E.M. of expression for RAB3 isoforms and RAB27A in the other
PANC-1iNGN3 clones (Fig. 2B) after 2 mg/ml doxycycline for 48 h.
*P!0.05 compared to ‘Kdox’ treatment.
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Figure 4 Timing of RAB3B expression following the induction of
NGN3 in PANC-1iNGN3 cells. The relative expression of RAB3B and
NEUROD1 is shown following the addition of 2 mg/ml doxycycline
to PANC-1iNGN3 clone 51. Bars show meanGS.E.M. from two
experiments. *P!0.05 following analysis by ANOVA and
Dunnett’s post hoc test.
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blotting revealed dose-responsive NGN3 expression
(Fig. 2A). Four clones, 9, 15, 40 and 51, were analysed in
greater detail. The ability of these clones to induce functional
NGN3 protein after the addition of dox to the media was
assessed using a luciferase construct containing two E-box
motifs from the wild-type mouse NeuroD1 50 ﬂanking region
(Fig. 2B; Huang et al. 2000). All the four clones increased
luciferase activity on the addition of dox to the media
(Fig. 2C). Clone 51 gave the most reproducible results with
least background luciferase activity and, thus, was chosen for
the induction of NGN3 and subsequent microarray analysis
(see Supplementary Methods, see section on supplementary
data given at the end of this article). As expected, NGN3
upregulation was detected by the array (Fig. 2D). The gene
encoding RAB3B was also identiﬁed from candidates whose
expression was induced at least twofold by 2 mg/ml dox
treatment for 48 h. Reassuringly, both NGN3 and RAB3B
proteins showed dose-responsive increases following dox
treatment of clone 51 (Fig. 2E and F).
Expression of RAB3 family members and RAB27A in
NGN3-inducible PANC-1 cells
In the mouse central nervous system, Rab3 proteins functions
redundantly due to other co-expressed family members
(Schluter et al. 2004). In mouse b-cells, inactivation of
Rab3a and Rab27a, but not Rab3b, caused glucose intolerance
(Yaekura et al. 2003, Kasai et al. 2005). Therefore, we analysed
whether NGN3 expression led to the expression of other
RAB3 genes as well as RAB27A. Following the induction of
NGN3 for 48 h, neither RAB3A, RAB3C and RAB3D
family members nor RAB27A was increased in either clone
51 (Fig. 3A) or the other PANC-1iNGN3 cell clones (Fig. 3B).
RAB3B was signiﬁcantly increased in all the four PANC-
1iNGN3 clones, albeit to a lesser extent in clones 9, 15 and 40
than in clone 51. Spurious induction of RAB3B by the
antibiotic was excluded, as dox had no effect on RAB3B
expression in PANC-1 cells lacking the pTRE2–NGN3
vector (data not shown).
NGN3 is a transient requirement during mouse endocrine
cell differentiation (Schwitzgebel et al. 2000). As exocytosis of
stored hormone granules is a function of mature endocrine
cells, NGN3 would not be expected to directly regulate
RAB3B expression. We examined the timing of RAB3B
expression in the PANC-1iNGN3 cells. By northern blotting,
NGN3 transcripts were induced within 2 h of adding dox
(data not shown). mRNA levels of NEUROD1, a direct
target of NGN3 action (Huang et al. 2000), were increased by
w40% at 6 h and doubled at 12 h. In contrast, RAB3B
transcripts accumulated relatively slowly, levels being
increased only by w50% at 24 h after the addition of
ABC
DEF
52 dpc
NGN3 NGN3 NGN3
8 wpc 10 wpc
10 wpc 10 wpc 10 wpc
NGN3/PDX1 NGN3/RAB3B NGN3/insulin
Figure 5 Expression of NGN3 during human pancreas development. (A–F) NGN3 immunohistochemistry in sections of
developing human pancreas at 52 dpc (A), 8 wpc (B, arrows point to positive cells) and 10 wpc (C–F). Dual
immunoﬂuorescence of NGN3 (red) and PDX1 (green) is shown in (C). (E and F) Dual immunoﬂuorescence of NGN3 with
RAB3B(E)andinsulin(F).Arrowsin(F)pointtoNGN3-positivenuclei.Sizebarsrepresent150 mm(A–C)and40 mm(D–F).
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RAB3B transcription is indirect and mediated through
other transcription factors. We used RNAi to moderate the
increase in NEUROD1 expression (Supplementary Figure 1,
see section on supplementary data given at the end of
this article). The downstream induction of RAB3B was
unaltered, indicating that it does not rely on NEUROD1
(data not shown).
Expression of RAB3B during human pancreas development
and in islets
From analyses offour specimens at 50 and 52 dpc, the human
embryonic pancreas was largely devoid of cells positive for
NGN3 (Fig. 5A). In two specimens at 8 wpc, isolated
epithelial cells with nuclei stained for NGN3 immunor-
eactivity were apparent centrally within the organ (arrows in
Fig. 5B). At this stage, we have previously reported occasional
insulin-positive cells in the same location (Piper et al. 2004).
Similarly positioned NGN3-positive cells were more numer-
ous within two specimens of larger pancreas at 10 wpc
(Fig. 5C) and they did not co-localise with PDX1 (Fig. 5D).
In keeping with an indirect induction by NGN3, neither
RAB3B nor insulin-positive cells stained for NGN3 (Fig. 5E
and F). RAB3B was ﬁrst detected weakly by immuno-
histochemistry in the cytoplasm of clustered cells adjacent to
the duct-like epithelial structures of the foetal pancreas at
10 wpc (Fig. 6A and B). It was detected more robustly in the
earliest foetal islets at 12 wpc (Fig. 6C) and in the cells of adult
islets (Fig. 6D). RAB3B was not found in ducts or acinar cells
(Fig. 6D) of the adult pancreas. At 10 wpc, RAB3B
co-localised with insulin and glucagon (Fig 6E–J). In the
adult pancreas, RAB3B extensively co-localised with insulin
but was somewhat variable in different b-cells (Fig. 7A–C).
Some RAB3B was present in some a- and d-cell but at
relatively low level (Fig. 7D–I). In contrast, RAB3B did not
co-localise with pancreatic polypeptide in the adult pancreas
(Fig. 7G–L). Consistent with Fig. 6D, RAB3B was not
detected in CK19-positive duct cells in the adult pancreas
(Fig. 7M–O). These data are consistent with the timing of
RAB3B expression following its induction by NGN3 in
PANC-1iNGN3 cells (Fig. 4).
By real-time PCR, RAB3B was detected robustly in adult
islets. Its transcripts were w500-fold increased compared to
ABCD
EFG
J I H
8 wpc 10 wpc
10 wpc 10 wpc 10 wpc
10 wpc 10 wpc 10 wpc
12 wpc Adult
RAB3B RAB3B RAB3B RAB3B ∗
Insulin/RAB3B Insulin
Grucagon Grucagon/RAB3B
RAB3B
RAB3B
Figure 6 Expression of RAB3B during human pancreas development. (A–D) RAB3B
immunohistochemistry in sections of developing human pancreas at 8 wpc (A), 10 wpc
(B, arrow points to faintly positive cell cluster) and 12 wpc (C), and in the adult pancreas
(D, arrow and star indicate duct and acinar tissue respectively). (E–J) Individual and dual
immunoﬂuorescence at 10 wpc counterstained with DAPI (blue). Size bar represents 150 mm
(A–C), 250 mm (D) and 40 mm (E–J).
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Figure 7 Expression of RAB3B in the adult pancreas. (A–O) Immunoﬂuo-
rescence counterstained with DAPI (blue) in sections of the adult pancreas.
Size bar represents 40 mm (A–F and J–O) and 150 mm (G–H).
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increased compared to RAB27A (Fig. 8). RAB3D did not
amplify despite 40 cycles of PCR, implying very low or
absent expression compared to the other isoforms under
investigation.
Discussion
Studies in mice have proven that Ngn3 is required for
pancreatic endocrine cell commitment. Without the bHLH
transcription factor, the islet differentiation programme fails
(Gradwohl et al. 2000). Conversely, driving ectopic Ngn3
expression in all pancreatic progenitor cells leads to premature
over-commitment to an endocrine cell fate (Apelqvist et al.
1999). Lineage tracing of Ngn3-positive cells marks all
mature pancreatic endocrine cell types (Gu et al. 2002).
The transcription factor is extinguished before terminal
differentiation and hormone expression (Schwitzgebel et al.
2000). Thus, it can be concluded that, in rodents, transient
Ngn3 expression in an appropriate number of pancreatic
epithelial progenitor cells is the normal mechanism for islet
development and also appears important for potential b-cell
regeneration in adult mice (Xu et al. 2008). In this study,
consistent with previous data describing NGN3 transcripts in
the human foetal pancreas at 8 wpc (Castaing et al. 2005), we
found the transcription factor present at 8 and 10 wpc within
central cells of the pancreas where endocrine differentiation is
known to predominate away from the pro-proliferative,
exocrine-inducing effects of peri-pancreatic mesenchyme
(Miralles et al. 1998, Polak et al. 2000, Elghazi et al. 2002,
Piper et al. 2004). At this stage of development, large numbers
of insulin-positive cells are apparent before organisation into
islets at the end of the ﬁrst trimester (Piper et al. 2004).
Coupled with the identiﬁcation of hypomorphic NGN3
mutations in patients with juvenile-onset diabetes (Wang et al.
2006, Jensen et al. 2007), these ﬁndings make in vitro models
useful in the search for downstream target genes of NGN3
expression in human (Heremans et al. 2002, Mellitzer et al.
2006) and in mouse cell types (Gasa et al. 2004).
Our in vitro cell line model to study the downstream
consequences of NGN3 expression is an imperfect replica of
human foetal pancreatic progenitors. In our experience,
PANC-1 cells lack PDX1 protein. On the microarray,
hybridisation signal was weak for PDX1 and unaltered by
the dox treatment. However, similar in vitro models have been
used by others (Gasa et al. 2004) and PDX1 was absent in the
NGN3-positive foetal pancreatic cells both in this study and
in mouse (Schwitzgebel et al. 2000). Our cloned cells did
uniformly express SOX9 and CK19 mimicking foetal
pancreatic progenitor cells and an adult ductal phenotype.
Nevertheless, by the ectopic expression of a single gene in a
tumour cell line, it is inconceivable to generate bona ﬁde
b-cell precursors with complete, faithful gene expression
proﬁles. Hence, our model of inducible NGN3 expression
was used as a tool to identify downstream candidate markers
of human b-cells for validation in the native cell type. NGN3
expression promptly activated NEUROD1, which encodes a
transcription factor that has been linked causally with various
forms of non-autoimmune diabetes (Frayling et al. 2001). Our
model also allowed detection of RAB3B, which was
subsequently shown to localise robustly to the human foetal
and adult b-cells.
There are four RAB3 family members. Regazzi et al.
(1996) previously showed RAB3B and RAB3C, but not
RAB3A, by immunoblotting of whole human islets,
comprising multiple hormone-secreting cell types. At that
time, RAB3D was not assessed. In rat and mouse, Rab3a and
Rab27a are very important regulators of exocytosis, both
in vitro and in vivo,i nb-cells (Regazzi et al. 1996, Yi et al.
2002, Waselle et al. 2003, Yaekura et al. 2003, Kasai et al. 2005,
Abderrahmani et al. 2006). Through the interaction with a
network of interacting proteins, they coordinate the
intracellular trafﬁcking of insulin granules that culminate in
docking at the cell membrane and insulin release (Yi et al.
2002, Waselle et al. 2003). Rab3a and Rab27a knockout mice
show defects in glucose-stimulated insulin secretion (GSIS)
similar to those observed in patients with type 2 diabetes and
in mice lacking the glucagon-like peptide-1 (GLP-1) receptor
(Scrocchi et al. 1996, Yaekura et al. 2003, Aizawa & Komatsu
2005, Kasai et al. 2005). Furthermore, hyperglycaemia
drastically reduced levels of Rab3a and Rab27a protein
in rat b-cells as a consequence of expression of the
transcriptional repressor, inducible cAMP early repressor
(Abderrahmani et al.2 0 0 6 ). It transpires that GLP-1
potentiation of insulin secretion requires a complex between
the cAMP sensor protein cAMP–GEFII, bound to the
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Figure 8 Expression of RAB3 family members and RAB27A in
isolated human adult islets. Real-time PCR analysis of RAB3
isoforms and RAB27A in adult islets expressed relative to b-ACTIN
transcript levels. RAB3D did not amplify despite the use of more
than 40 cycles of PCR.
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Rab-interacting molecule 2 (RIM2; Ozaki et al. 2000,
Kashima et al. 2001, Fujimoto et al. 2002, Shibasaki et al.
2004). RIM2 then interacts with the RAB protein at the
insulin granule, thus linking GLP-1 signalling and events at
the ATP-sensitive potassium channel to insulin secretion.
This emerging understanding of an important mechanism
underlying GSIS makes the identiﬁcation of the prevalent
RAB isoform(s) in human b-cells important.
In this study, RAB3B was the only family member induced
as a consequence of NGN3 expression. Its induction by
NGN3 occurred later than that of NEUROD1, which, along
with the non-overlapping expression proﬁles in develop-
mental material, implies indirect regulation of RAB3B by
NGN3. We show that RAB3B was extensively localised to
b-cells both during human foetal development and in adult
islets with some expression in some adult a- and d-cells.
Analysis of human adult islets demonstrated RAB3B
expression to be approximately equal to the transcript
numbers of b-ACTIN, present in all islet cell types, and
greatly in excess of those for RAB3A, RAB3C, RAB3D and
RAB27A. The level of RAB3B transcripts detected equates to
w20–50% of those which we have previously found for
insulin (data not shown). In the mouse central nervous
system, Rab3 family members regulate the exocytosis of
neurotransmitters in a redundant manner, all isoforms
needing inactivation to generate an epileptic phenotype
(Schluter et al. 2004). This raises the question of whether
redundant function could also affect pancreatic b-cell
function. Although feasible, this seems unlikely: RAB3A
and RAB3C transcripts were only weakly detected and
RAB3D was not detected in islets whereas in the central
nervous system, under normal conditions, all Rab3 isoforms
are expressed (Schluter et al. 2004); in in vitro analysis of rat
melanotrophs, Rab3b could not substitute for the function of
Rab3a (Rupnik et al. 2007); inactivation of either Rab3a or
Rab27a in isolation produced glucose intolerance in mice
(implying non-redundant function; Yaekura et al. 2003, Kasai
et al. 2005); over-expression of Rab3a and Rab27a protein in
MIN6 cells generated different effects on insulin secretion
(Yi et al. 2002); and in dopaminergic nerves, over-expressing
RAB3B, but not RAB3A, was protective in the models of
Parkinson’s disease (Chung et al. 2009). Interestingly, on
searching the Unigene database, Rab3b is absent from cDNA
libraries generated from mouse or rat insulinoma cell lines.
Twelve of the 13 pancreatic clones for human RAB3B arise
from the islet or insulinoma sources. Conversely, RAB3A,
inactivation of which causes glucose intolerance in mice
(Yaekura et al. 2003), has not been identiﬁed from Unigene
human islet or insulinoma cDNA libraries.
There is a clear involvement of mutations in the pathway
between the ATP-sensitive potassium channel and insulin
secretion as causes of permanent neonatal diabetes (Gloyn
et al. 2004). RAB3B localises to 1p31–p32, a locus previously
linked to glucose intolerance and diabetes (Hsueh et al. 2003).
We have conducted preliminary screens in three cases of
permanent neonatal diabetes with linkage to this locus
without identifying causative mutations in the RAB3B
coding region. Irrespective of this, the potential for agents
targeted at RAB function as novel potentiators of GSIS has
already been proposed (Aizawa & Komatsu 2005). It will be
important to ensure such efforts target the appropriate
protein. In this study, we identiﬁed RAB3B as an indirect
target of NGN3 expression. Under normal circumstances,
RAB3B is clearly the predominant family member in human
islets representing a signiﬁcant difference in gene expression
across species. Speciﬁcally, neither RAB3A nor RAB27A
appears as likely to play the important role in human b-cells
that has been described for the equivalent rodent cells
(Regazzi et al. 1996, Yi et al. 2002, Waselle et al. 2003, Kasai
et al. 2005, Abderrahmani et al. 2006).
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